NASDAQ:HRTS Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News → The Gold Grab of the Century (From Colonial Metals) (Ad) Free HRTS Stock Alerts $32.27 +0.42 (+1.32%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share Today's Range$32.11▼$32.4150-Day Range$30.80▼$34.8952-Week Range$26.26▼$35.58Volume13,400 shsAverage Volume27,788 shsMarket Capitalization$60.99 millionAssets Under Management$60.16 millionDividend YieldN/ANet Expense Ratio0.75% Stock AnalysisStock AnalysisChartHeadlinesHoldingsRatingsSocial MediaStock AnalysisChartHeadlinesHoldingsRatingsSocial Media Get Tema Cardiovascular and Metabolics ETF alerts: Email Address About Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Read More HRTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HRTS ETF News HeadlinesMay 3, 2024 | americanbankingnews.comTema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Trading Up 0.3%March 17, 2024 | finance.yahoo.comXLV240322C00139500 (XLV240322C00139500) Interactive Stock Chart - Yahoo FinanceMay 6, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.March 17, 2024 | finance.yahoo.comXLV240322P00147000 (XLV240322P00147000) Interactive Stock Chart - Yahoo FinanceMarch 17, 2024 | msn.comSpain considers providing free condoms to young people amid rise in sexually transmitted infectionsMarch 16, 2024 | finance.yahoo.comXLV240322C00134000 (XLV240322C00134000) Interactive Stock Chart - Yahoo FinanceMarch 15, 2024 | msn.comWorld Sleep Day: top tips for how to get a good night's sleepMarch 15, 2024 | ca.finance.yahoo.comNVO Mar 2024 131.000 putMay 6, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.March 15, 2024 | ca.finance.yahoo.comXLV Apr 2024 144.500 putSee More Headlines Receive HRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerTema Global Fund NameTema Cardiovascular and Metabolics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:HRTS Inception Date11/20/2023 Fund ManagerDavid Song, Yuri Khodjamirian Previous SymbolNASDAQ:HRTS WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings45 Fund Statistics Assets Under Management$60.16 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorTema Global Limited CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares1,890,000Beta0.95 Creation Unit10,000 Creation Fee$500.00 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Tema Cardiovascular and Metabolics ETF ExpensesTypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.54%0.48%0.51%Other Expenses0.00%0.72%0.54%0.34%0.58%Total Expense0.99%0.72%0.70%0.58%0.70%Fee Waiver-0.24%-0.76%-0.55%-0.22%-0.57%Net Expense0.75%0.59%0.60%0.54%0.58% Tema Cardiovascular and Metabolics ETF (HRTS) Holdings & ExposureTop 10 HRTS HoldingsVertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 5.42%Eli Lilly and Company(NYSE:LLY)Holding Weight: 5.31%Novo Nordisk A/S Class BHolding Weight: 5.21%Amgen(NASDAQ:AMGN)Holding Weight: 4.90%DexCom(NASDAQ:DXCM)Holding Weight: 4.33%Cytokinetics(NASDAQ:CYTK)Holding Weight: 3.08%Edwards Lifesciences(NYSE:EW)Holding Weight: 2.96%Insulet(NASDAQ:PODD)Holding Weight: 2.88%Medtronic(NYSE:MDT)Holding Weight: 2.87%Ascendis Pharma A/S(NASDAQ:ASND)Holding Weight: 2.83%HRTS Sector ExposureHRTS Industry ExposureFull Holdings Details Similar ETFsGlobal X Aging Population ETFNASDAQ:AGNGGlobal X Data Center & Digital Infrastructure ETFNASDAQ:DTCRGlobal X Data Center & Digital Infrastructure ETFNASDAQ:VPNAXS 2X Innovation ETFNASDAQ:TARKiShares Paris-Aligned Climate MSCI World ex USA ETFNASDAQ:PABD HRTS ETF - Frequently Asked Questions How have HRTS shares performed in 2024? Tema Cardiovascular and Metabolics ETF's stock was trading at $30.61 at the beginning of 2024. Since then, HRTS stock has increased by 5.4% and is now trading at $32.27. View the best growth stocks for 2024 here. What does HRTS invest in? Tema Cardiovascular and Metabolics ETF is a equity fund issued by Tema Global. HRTS focuses on theme investments. The fund's investments total to approximately $60.16 million assets under management. What stocks does Tema Cardiovascular and Metabolics ETF hold? HRTS invests in 45 holdings. Some of the stocks in their portfolio include Vertex Pharmaceuticals (VRTX), Eli Lilly and Company (LLY), Amgen (AMGN), DexCom (DXCM), Cytokinetics (CYTK), Edwards Lifesciences (EW), Insulet (PODD), Medtronic (MDT), Ascendis Pharma A/S (ASND) and Boston Scientific (BSX). What is the management fee for Tema Cardiovascular and Metabolics ETF? Tema Cardiovascular and Metabolics ETF's management fee is 0.99% and has no other recorded expenses. However, HRTS has a fee waiver of -0.24% to reimburse the expenses. The net expense ratio for HRTS is 0.75%. How do I buy shares of Tema Cardiovascular and Metabolics ETF? Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HRTS) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
